Oramed Pharmaceuticals Inc. (ORMP) insider trading: who bought and sold

ORMP insider activity

31 transactions on file (0 open-market purchases and 2 open-market sales).

Scheduled or decided

2 open-market sales by ORMP insiders, between Jul 1, 2026 and Jul 1, 2026.

A sale made under a trading plan agreed months earlier is not the same event as one decided that week, and the filing itself says which.

Discretionary. The box was on the form and was not ticked. The sale was made at the prevailing price without a pre-arranged plan behind it.: $942K; 2 filings · 2 people
Planned (10b5-1). The filer ticked the Form 4's 10b5-1 box. The sale ran under a trading plan adopted before the trade, so it is a schedule executing rather than a view taken this week.: None; no sales on file
Not stated. The filing does not say. Either it predates the April 2023 checkbox, or nothing has re-read it since. This tab will not guess which of the other two it was.: None; no sales on file

Recent transactions 31 filed

Date	Insider	Type	Shares	Price	Value	Owned after
2026-07-02	Hexter Joshua COO & CBO Option exercise	Option exercise	+50,000	$3.69	+184.5K	1,073,384
2026-07-01	Hexter Joshua COO & CBO Open-market sale Discretionary	Open-market sale Discretionary	−137,000	$4.46	−611.43K	1,023,384
2026-07-01	Gabay Avraham Chief Financial Officer Open-market sale Discretionary	Open-market sale Discretionary	−73,360	$4.51	−330.74K	671,785
2026-03-30	KIDRON NADAV President and CEO · Director Tax withholding	Tax withholding	−44,818	$3.31	−148.35K	3,422,243
2026-03-30	Kidron Miriam Chief Scientific Officer · Director Tax withholding	Tax withholding	−435,084	$3.31	−1.44M	1,133,138

26 more transactions are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Each insider's stake 2 people

Insider	Role	On Sep 23, 2025	Now	Change	Sold	Shape
Hexter JoshuaCOO & CBO	COO & CBO	1,160,384	1,023,384	−11.81%	$611K$611K no plan
Gabay AvrahamChief Financial Officer	Chief Financial Officer	745,145	671,785	−9.85%	$331K$331K no plan

What each insider held after every open-market trade, over the last twelve months.

The figure is each person’s holding as they reported it. It counts one class of stock and excludes grants, option exercises and shares withheld for tax, so a stake can fall here while somebody’s total holding does not. Since April 2023 a Form 4 states whether a trade ran under a pre-arranged 10b5-1 plan; an older one does not, and those dollars read “not stated” rather than being counted either way.

Ask about Oramed Pharmaceuticals Inc.

The assistant answers from what ORMP has actually filed: 18 annual reports filed with the SEC, 31 Form 4 filings from the last year and 1 fund that holds it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from ORMP's filings and figures. One a day without an account; a free account has its own, and no card.

Get the next ORMP Form 4 in your inbox: a free account, no card, one email a day at most.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with ORMP's filings

Source

From SEC Form 4 filings, filed within two business days of a transaction.

They are filed by officers, directors and 10%-owners. “Indirect” holdings (a trust, an LLC, a family member) are included and not distinguished from direct ones in this table.

Past transactions say nothing about future ones, and none of this is investment advice.

Ask about Oramed Pharmaceuticals Inc.

What an account lets you do with ORMP's filings

After each open-market trade